Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead
Eli Lilly's newly approved weight-loss pill is expected to generate billions in sales as soon as this year, with analysts betting it will quickly narrow Novo
April 02, 2026
Supreme Court ruling on race-based redistricting prompts quick action in some states
Cultural groups urge federal judge to block Kennedy Center renovations
Wall Street ends mixed ahead of big tech earnings
Carvana's first-quarter profit rises on used-car demand
Sanoja has 2-out bloop single to spark Marlins to 3-2 victory over Dodgers
MGM Resorts' quarterly profit misses estimates amid slower Las Vegas business